# FDA 483 - Central California Blood Center/ Clovis Donor Center - December 11, 2024

Source: https://www.keypedia.com/records/483/central-california-blood-center-clovis-donor-center/985280d7-da56-496e-b038-ce80ea2e3b8c

> FDA 483 for Central California Blood Center/ Clovis Donor Center on December 11, 2024. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Central California Blood Center/ Clovis Donor Center
- Inspection Date: 2024-12-11
- Product Type: biologics
- Office Name: San Francisco District Office
- Summary: The FDA inspected Central California Blood Center/ Clovis Donor Center in Clovis, CA, and issued a Form 483 with two observations. The inspection revealed deficiencies in providing adequate storage space for blood and blood components, leading to potential contamination risks. Additionally, the facility failed to ensure that phlebotomists consistently followed standard operating procedures for blood sample collection, specifically regarding the inversion of sample tubes.

## Related Officers

- [Conor J. Mccarron](https://www.keypedia.com/people/conor-j-mccarron/280401e4-b080-4ba8-ab35-d3b16e91c2b1)

Company: https://www.keypedia.com/companies/central-california-blood-center-clovis-donor-center/fa5794b3-750f-490c-8af5-8af9006a647f

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df